Progression and novel strategies in vaccines and immunization

Image

Vaccine is a global platform to discuss about new vaccines  and learn Vaccine,  Immunology, Bacterial Vaccines, HIV/AIDS Vaccines, Toxoid Vaccines, Children Vaccines, Unconventional Vaccines, Vaccine Industry, Protein Based Vaccines, Plant Derived Vaccines, Vaccine Safety & Efficacy, Geriatric Immunization, Immunizations, Vaccines & Immunizations, Cancer Vaccines , Travel Immunization,  DNA Vaccines, HPV Vaccines, Adjuvants & Delivery Technologies, Vaccines Clinical Trials, Viral Vaccines, Antibodies Research, Neonate Vaccines, Immune Mediated Vaccines, Mosquito-Borne Diseases-Vaccines, Human Vaccines, Animal Vaccination, Vaccines Research & Development. Vaccine Congress 2019 is devoted to the advancement and dissemination of new knowledge about all aspects of the immune response in health, in disease, and after vaccination.

Vaccine & Immunization:

The goal of public health is to prevent disease. It's much easier and more cost-effective to prevent a disease than to treat it. That's exactly what immunizations aim to do. Immunizations, or vaccines as they're also known, safely and effectively use a small amount of a weakened or killed virus or bacteria or bits of lab-made protein that imitate the virus in order to prevent infection by that same virus or bacteria.

Pathology and Immunology:

Immunopathology is a branch of medicine that deals with immune responses associated with the disease. It incorporates the investigation of the pathology of a life form, organ framework, or ailment concerning the insusceptible framework, invulnerability, and resistant reactions. In science, it alludes to the harm caused to a creature by its own resistant reaction, because of a contamination. Two decade of clinical involvement with immunomodulatory medicines for various sclerosis points to unmistakable immunological pathways that drive ailment backslides and movement. Immunopathology could allude to how the outside antigens cause the invulnerable framework to have a reaction or issues that can emerge from a living being's own particular resistant reaction on itself. There are sure issues or blames in the invulnerable framework that can prompt more genuine sickness or malady.

Open access planning to release a year end special issue has announced almost 50% discount on article publication charges to celebrate its journey for publishing articles with in the short time.

 A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing.

Manuscripts can be forwarded to the Editorial Office at autoimmunedis@eclinicalsci.com

How we work:

  • After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
  • A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
  • Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Color Art: In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

 

Media Contact:
Rutherford
Journal Manager
Journal of Autoimmune Disorders
Email: autoimmunedis@eclinicalsci.com